{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:53:45Z","timestamp":1787792025147,"version":"build-2784847793"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","funder":[{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","award":["1U79SM080000-01"],"award-info":[{"award-number":["1U79SM080000-01"]}],"id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s40120-017-0078-4","type":"journal-article","created":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T01:19:50Z","timestamp":1501204790000},"page":"247-257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Use of Prazosin for Pediatric PTSD-Associated Nightmares and Sleep Disturbances: A Retrospective Chart Review"],"prefix":"10.1007","volume":"6","author":[{"given":"Brooks R.","family":"Keeshin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela P.","family":"Presson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Berkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Strawn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,28]]},"reference":[{"key":"78_CR1","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/da.20736","volume":"28","author":"MS Scheeringa","year":"2011","unstructured":"Scheeringa MS, Zeanah CH, Cohen JA. PTSD in children and adolescents: toward an empirically based algorithma. Depress Anxiety. 2011;28:770\u201382.","journal-title":"Depress Anxiety"},{"key":"78_CR2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.5664\/jcsm.2678","volume":"9","author":"B Kovachy","year":"2013","unstructured":"Kovachy B, O\u2019Hara R, Hawkins N, Gershon A, Primeau MM, Madej J, et al. Sleep disturbance in pediatric PTSD: current findings and future directions. J Clin Sleep Med. 2013;9:501\u201310.","journal-title":"J Clin Sleep Med"},{"key":"78_CR3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.chc.2013.12.002","volume":"23","author":"BR Keeshin","year":"2014","unstructured":"Keeshin BR, Strawn JR. Psychological and pharmacologic treatment of youth with posttraumatic stress disorder: an evidence-based review. Child Adolesc Psychiatr Clin N Am. 2014;23:399\u2013411.","journal-title":"Child Adolesc Psychiatr Clin N Am."},{"key":"78_CR4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cpr.2016.05.006","volume":"47","author":"N Morina","year":"2016","unstructured":"Morina N, Koerssen R, Pollet TV. Interventions for children and adolescents with posttraumatic stress disorder: a meta-analysis of comparative outcome studies. Clin Psychol Rev. 2016;47:41\u201354.","journal-title":"Clin Psychol Rev."},{"key":"78_CR5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/15374410701818293","volume":"37","author":"WK Silverman","year":"2008","unstructured":"Silverman WK, Ortiz CD, Viswesvaran C, Burns BJ, Kolko DJ, Putnam FW, et al. Evidence-based psychosocial treatments for children and adolescents exposed to traumatic events. J Clin Child Adolesc Psychol. 2008;37:156\u201383.","journal-title":"J Clin Child Adolesc Psychol."},{"key":"78_CR6","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/chi.0b013e3180547105","volume":"46","author":"JA Cohen","year":"2007","unstructured":"Cohen JA, Mannarino AP, Perel JM, Staron V. A pilot randomized controlled trial of combined trauma-focused CBT and sertraline for childhood PTSD symptoms. J Am Acad Child Adolesc Psychiatry. 2007;46:811\u20139.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"78_CR7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/cap.2009.0115","volume":"20","author":"AS Robb","year":"2010","unstructured":"Robb AS, Cueva JE, Sporn J, Yang R, Vanderburg DG. Sertraline treatment of children and adolescents with posttraumatic stress disorder: a double-blind, placebo-controlled trial. J Child Adolesc Psychopharmacol. 2010;20:463\u201371.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"78_CR8","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1345\/aph.1Q548","volume":"45","author":"JR Strawn","year":"2011","unstructured":"Strawn JR, Keeshin BR. Successful treatment of posttraumatic stress disorder with prazosin in a young child. Ann Pharmacother. 2011;45:1590\u20131.","journal-title":"Ann Pharmacother"},{"key":"78_CR9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1089\/cap.2009.0043","volume":"19","author":"JR Strawn","year":"2009","unstructured":"Strawn JR, Delbello MP, Geracioti TD. Prazosin treatment of an adolescent with posttraumatic stress disorder. J Child Adolesc Psychopharmacol. 2009;19:599\u2013600.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"78_CR10","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/01.CHI.0000052509.98293.97","volume":"42","author":"Z Brkanac","year":"2003","unstructured":"Brkanac Z, Pastor JF, Storck M. Prazosin in PTSD. J Am Acad Child Adolesc Psychiatry. 2003;42:384\u20135","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"key":"78_CR11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1089\/cap.2012.0119","volume":"23","author":"DF Connor","year":"2013","unstructured":"Connor DF, Grasso DJ, Slivinsky MD, Pearson GS, Banga A. An open-label study of guanfacine extended release for traumatic stress related symptoms in children and adolescents. J Child Adolesc Psychopharmacol. 2013;23:244\u201351.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"78_CR12","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/da.20292","volume":"25","author":"JR Strawn","year":"2008","unstructured":"Strawn JR, Geracioti TD. Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder. Depress Anxiety. 2008;25:260\u201371.","journal-title":"Depress Anxiety"},{"key":"78_CR13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.smrv.2007.09.003","volume":"12","author":"A Germain","year":"2008","unstructured":"Germain A, Buysse DJ, Nofzinger E. Sleep-specific mechanisms underlying posttraumatic stress disorder: integrative review and neurobiological hypotheses. Sleep Med Rev. 2008;12:185\u201395.","journal-title":"Sleep Med Rev"},{"key":"78_CR14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0272-7358(03)00032-1","volume":"23","author":"AG Harvey","year":"2003","unstructured":"Harvey AG, Jones C, Schmidt DA. Sleep and posttraumatic stress disorder: a review. Clin Psychol Rev. 2003;23:377\u2013407.","journal-title":"Clin Psychol Rev."},{"key":"78_CR15","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1176\/appi.ajp.158.8.1227","volume":"158","author":"TD Geracioti","year":"2001","unstructured":"Geracioti TD, Baker DG, Ekhator NN, West SA, Hill KK, Bruce AB, et al. CSF norepinephrine concentrations in posttraumatic stress disorder. Am J Psychiatry. 2001;158:1227\u201330.","journal-title":"Am J Psychiatry"},{"key":"78_CR16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00004583-199403000-00004","volume":"33","author":"MD Bellis De","year":"1994","unstructured":"De Bellis MD, Lefter L, Trickett PK, Putnam FW. Urinary catecholamine excretion in sexually abused girls. J Am Acad Child Adolesc Psychiatry. 1994;33:320\u20137.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"78_CR17","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0006-3223(99)00044-X","volume":"45","author":"MD Bellis De","year":"1999","unstructured":"De Bellis MD, Baum AS, Birmaher B, Keshavan MS, Eccard CH, Boring AM, et al. A. E. Bennett Research Award. Developmental traumatology. Part I: biological stress systems. Biol Psychiatry. 1999;45:1259\u201370.","journal-title":"Biol Psychiatry"},{"key":"78_CR18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-2007-981461","volume":"39","author":"P Pervanidou","year":"2007","unstructured":"Pervanidou P, Chrousos GP. Post-traumatic Stress Disorder in children and adolescents: from Sigmund Freud\u2019s \u2018trauma\u2019 to psychopathology and the (Dys)metabolic syndrome. Horm Metab Res. 2007;39:413\u20139.","journal-title":"Horm Metab Res"},{"key":"78_CR19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1089\/cap.2014.0034","volume":"25","author":"BR Keeshin","year":"2015","unstructured":"Keeshin BR, Strawn JR, Out D, Granger DA, Putnam FW. Elevated salivary alpha amylase in adolescent sexual abuse survivors with posttraumatic stress disorder symptoms. J Child Adolesc Psychopharmacol. 2015;25:344\u201350.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"78_CR20","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/archpedi.1988.02150110122036","volume":"142","author":"R Famularo","year":"1988","unstructured":"Famularo R, Kinscherff R, Fenton T. Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study. Am J Dis Child. 1988;142:1244\u20137.","journal-title":"Am J Dis Child"},{"key":"78_CR21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/jts.20517","volume":"23","author":"NR Nugent","year":"2010","unstructured":"Nugent NR, Christopher NC, Crow JP, Browne L, Ostrowski S, Delahanty DL. The efficacy of early propranolol administration at reducing PTSD symptoms in pediatric injury patients: a pilot study. J Trauma Stress. 2010;23:282\u20137.","journal-title":"J Trauma Stress"},{"key":"78_CR22","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/CHI.0b013e3181b26e9f","volume":"48","author":"MH Bloch","year":"2009","unstructured":"Bloch MH, Panza KE, Landeros-Weisenberger A, Leckman JF. Meta-analysis: treatment of attention-deficit\/hyperactivity disorder in children with comorbid tic disorders. J Am Acad Child Adolesc Psychiatry. 2009;48:884\u201393.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"78_CR23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1056-4993(02)00102-5","volume":"12","author":"CL Donnelly","year":"2003","unstructured":"Donnelly CL. Pharmacologic treatment approaches for children and adolescents with posttraumatic stress disorder. Child Adolesc Psychiatr Clin N Am. 2003;12:251\u201369.","journal-title":"Child Adolesc Psychiatr Clin N Am."},{"key":"78_CR24","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/00004583-199609000-00022","volume":"35","author":"RJ Harmon","year":"1996","unstructured":"Harmon RJ, Riggs PD. Clonidine for posttraumatic stress disorder in preschool children. J Am Acad Child Adolesc Psychiatry. 1996;35:1247\u20139.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"78_CR25","first-page":"475","volume":"91","author":"DM Porter","year":"1999","unstructured":"Porter DM, Bell CC. The use of clonidine in post-traumatic stress disorder. J Natl Med Assoc. 1999;91:475\u20137.","journal-title":"J Natl Med Assoc"},{"key":"78_CR26","first-page":"371","volume":"57","author":"JP Horrigan","year":"1996","unstructured":"Horrigan JP, Barnhill LJ. The suppression of nightmares with guanfacine. J Clin Psychiatry. 1996;57:371.","journal-title":"J Clin Psychiatry"},{"key":"78_CR27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/cap.2008.0080","volume":"19","author":"FR Sallee","year":"2009","unstructured":"Sallee FR, Lyne A, Wigal T, McGough JJ. Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2009;19:215\u201326.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"78_CR28","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.biopsych.2006.06.032","volume":"61","author":"MA Raskind","year":"2007","unstructured":"Raskind MA, Peskind ER, Hoff DJ, Hart KL, Holmes HA, Warren D, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry. 2007;61:928\u201334.","journal-title":"Biol Psychiatry"},{"key":"78_CR29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4088\/JCP.v63n0705","volume":"63","author":"MA Raskind","year":"2002","unstructured":"Raskind MA, Thompson C, Petrie EC, Dobie DJ, Rein RJ, Hoff DJ, et al. Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder. J Clin Psychiatry. 2002;63:565\u20138.","journal-title":"J Clin Psychiatry"},{"key":"78_CR30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/JCP.0b013e3181dac52f","volume":"30","author":"MG Byers","year":"2010","unstructured":"Byers MG, Allison KM, Wendel CS, Lee JK. Prazosin versus quetiapine for nighttime posttraumatic stress disorder symptoms in veterans: an assessment of long-term comparative effectiveness and safety. J Clin Psychopharmacol. 2010;30:225\u20139.","journal-title":"J Clin Psychopharmacol"},{"key":"78_CR31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1176\/appi.ajp.160.2.371","volume":"160","author":"MA Raskind","year":"2003","unstructured":"Raskind MA, Peskind ER, Kanter ED, Petrie EC, Radant A, Thompson CE, et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry. 2003;160:371\u20133.","journal-title":"Am J Psychiatry"},{"key":"78_CR32","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/01.pra.0000364287.63210.92","volume":"15","author":"L Boynton","year":"2009","unstructured":"Boynton L, Bentley J, Strachan E, Barbato A, Raskind M. Preliminary findings concerning the use of prazosin for the treatment of posttraumatic nightmares in a refugee population. J Psychiatr Pract. 2009;15:454\u20139.","journal-title":"J Psychiatr Pract"},{"key":"78_CR33","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1080\/15299732.2016.1141150","volume":"17","author":"KC George","year":"2016","unstructured":"George KC, Kebejian L, Ruth LJ, Miller CWT, Himelhoch S. Meta-analysis of the efficacy and safety of prazosin versus placebo for the treatment of nightmares and sleep disturbances in adults with posttraumatic stress disorder. J Trauma Dissociation. 2016;17:494\u2013510.","journal-title":"J Trauma Dissociation"},{"key":"78_CR34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF00503830","volume":"317","author":"DB Menkes","year":"1981","unstructured":"Menkes DB, Baraban JM, Aghajanian GK. Prazosin selectively antagonizes neuronal responses mediated by alpha1-adrenoceptors in brain. Naunyn Schmied Arch Pharmacol. 1981;317:273\u20135.","journal-title":"Naunyn Schmied Arch Pharmacol"},{"key":"78_CR35","doi-asserted-by":"crossref","first-page":"932","DOI":"10.4088\/JCP.09r05446blu","volume":"71","author":"JR Strawn","year":"2010","unstructured":"Strawn JR, Keeshin BR, Delbello MP, Geracioti TD, Putnam FW. Psychopharmacologic treatment of posttraumatic stress disorder in children and adolescents: a review. J Clin Psychiatry. 2010;71:932\u201341.","journal-title":"J Clin Psychiatry"},{"key":"78_CR36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0167-5273(91)90379-4","volume":"31","author":"J Hasford","year":"1991","unstructured":"Hasford J, Bussmann WD, Delius W, Koepcke W, Lehmann K, Weber E. First dose hypotension with enalapril and prazosin in congestive heart failure. Int J Cardiol. 1991;31:287\u201393.","journal-title":"Int J Cardiol"},{"key":"78_CR37","volume-title":"UCLA PTSD Reaction Index: DSM-5 Version","author":"RS Pynoos","year":"2014","unstructured":"Pynoos RS, Steinberg AM. UCLA PTSD Reaction Index: DSM-5 Version. Los Angeles, CA, USA: National Center for Child Traumatic Stress; 2014"},{"key":"78_CR38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00005053-199708000-00003","volume":"185","author":"JG Armstrong","year":"1997","unstructured":"Armstrong JG, Putnam FW, Carlson EB, Libero DZ, Smith SR. Development and validation of a measure of adolescent dissociation: the adolescent dissociative experiences scale. J Nerv Ment Dis. 1997;185:491\u20137.","journal-title":"J Nerv Ment Dis."},{"key":"78_CR39","first-page":"76","volume-title":"ECDEU Assessment Manual for Psychopharmacology","year":"1976","unstructured":"Guy W, editor. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: National Institute of Mental Health; 1976. pp. 76\u2013338"},{"key":"78_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jts.21780","volume":"26","author":"AM Steinberg","year":"2013","unstructured":"Steinberg AM, Brymer MJ, Kim S, Briggs EC, Ippen CG, Ostrowski SA, et al. Psychometric properties of the UCLA PTSD reaction index: part I. J Trauma Stress. 2013;26:1\u20139.","journal-title":"J Trauma Stress"},{"key":"78_CR41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jts.21755","volume":"26","author":"JD Elhai","year":"2013","unstructured":"Elhai JD, Layne CM, Steinberg AM, Brymer MJ, Briggs EC, Ostrowski SA, et al. Psychometric properties of the UCLA PTSD reaction index. Part II: investigating factor structure findings in a national clinic-referred youth sample. J Trauma Stress. 2013;26:10\u20138.","journal-title":"J Trauma Stress"},{"key":"78_CR42","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","volume":"54","author":"AJ Rush","year":"2003","unstructured":"Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, et al. The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54:573\u201383.","journal-title":"Biol Psychiatry"},{"key":"78_CR43","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00004583-199704000-00018","volume":"36","author":"B Birmaher","year":"1997","unstructured":"Birmaher B, Khetarpal S, Brent D, Cully M, Balach L, Kaufman J, et al. The screen for child anxiety related emotional disorders (SCARED): scale construction and psychometric characteristics. J Am Acad Child Adolesc Psychiatry. 1997;36:545\u201353.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"78_CR44","first-page":"7","volume":"4","author":"N Moore","year":"1994","unstructured":"Moore N, Fresel J, Joannid\u00e8s R, Compagnon P, Thuillez C. A comparison of the hemodynamic effects of urapidil, prazosin, and clonidine in healthy volunteers. Blood Press Suppl. 1994;4:7\u201312.","journal-title":"Blood Press Suppl"},{"key":"78_CR45","first-page":"II71","volume":"6","author":"JL Reid","year":"1984","unstructured":"Reid JL, Campbell BC, Hamilton CA. Withdrawal reactions following cessation of central alpha-adrenergic receptor agonists. Hypertension. 1984;6:II71\u20135.","journal-title":"Hypertension."},{"key":"78_CR46","first-page":"215","volume":"5","author":"BC Campbell","year":"1985","unstructured":"Campbell BC, Reid JL. Regimen for the control of blood pressure and symptoms during clonidine withdrawal. Int J Clin Pharmacol Res. 1985;5:215\u201322.","journal-title":"Int J Clin Pharmacol Res"},{"key":"78_CR47","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.mayocp.2012.05.015","volume":"87","author":"S Kung","year":"2012","unstructured":"Kung S, Espinel Z, Lapid MI. Treatment of nightmares with Prazosin: a systematic review. Mayo Clin Proc. 2012;87:890\u2013900.","journal-title":"Mayo Clin Proc."},{"key":"78_CR48","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1017\/S1092852900017107","volume":"13","author":"J Biederman","year":"2008","unstructured":"Biederman J, Melmed RD, Patel A, McBurnett K, Donahue J, Lyne A. Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD. CNS Spectr. 2008;13:1047\u201355.","journal-title":"CNS Spectr"},{"key":"78_CR49","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jaac.2013.11.009","volume":"53","author":"T Hirota","year":"2014","unstructured":"Hirota T, Schwartz S, Correll CU. Alpha-2 agonists for attention-deficit\/hyperactivity disorder in youth: a systematic review and meta-analysis of monotherapy and add-on trials to stimulant therapy. J Am Acad Child Adolesc Psychiatry. 2014;53:153\u201373.","journal-title":"J Am Acad Child Adolesc Psychiatry"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-017-0078-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T16:58:30Z","timestamp":1719334710000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40120-017-0078-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,28]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["78"],"URL":"https:\/\/doi.org\/10.1007\/s40120-017-0078-4","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,28]]}}}